Australia, March 19 -- Entera Bio Ltd., owns the trademark (2509991) for 'N-TAB' till Aug. 15, 2034.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations, namely, a drug delivery formulation that enables oral delivery of proteins and peptides; pharmaceutical preparations for use as peptide replacement therapy; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of metabolic conditions; pharmaceutical preparations for the treatment of short bowel syndrome; pharmaceutical preparations for the treatment of stress fractures; drug delivery agents that facilitate the delivery of pharmaceutical preparations.], 42 [Research and development services in the field of pharmaceutical preparations; development of pharmaceutical preparations and medicines; scientific research in the medical and pharmaceutical field, and consultancy and information relating thereto; design and development of new technology for others relating to oral delivery of proteins and peptides, and consultancy and information services relating thereto; research and development in the field of drug delivery systems.] and 45 [Licensing of intellectual property; licensing of technology.]
Type of Mark: Word
Date of Acceptance: Jan. 9
Registration Advertised: March 18
For further details contact G.E. Ehrlich (1995) Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2509991.
Disclaimer: Curated by HT Syndication.
